SCHEMBL6992518

SCHEMBL6992518

CCOC(=O)c1c(N)sc2c1CCN(Cc1ccc(OC)cc1)C2

nearest known ligand 0.81

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 7/20 0.81
MAPT P10636 4/20 0.81
MEN1 O00255 4/20 0.81
KMT2A Q03164 4/20 0.81
LMNA P02545 2/20 0.81
GAA P10253 4/20 0.66
POLB P06746 1/20 0.66
KDM4E B2RXH2 3/20 0.55
ALDH1A1 P00352 3/20 0.55
HPGD P15428 2/20 0.55
ALOX15 P16050 1/20 0.55
MAPK1 P28482 1/20 0.55
HSD17B10 Q99714 1/20 0.55
SMN1; SMN2 Q16637 2/20 0.50
ABCB1 P08183 1/20 0.50
HTT P42858 1/20 0.50
ABCG2 Q9UNQ0 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6993570 0.92 ADORA1 (0.84) ADORA1MAPTMEN1KMT2ALMNA
SCHEMBL7719502 0.91 ADORA1 (0.83) ADORA1MAPTMEN1KMT2ALMNA
SCHEMBL6993678 0.90 GAA (0.82) ADORA1MAPTMEN1KMT2ALMNA
Tinoridine SCHEMBL24761 0.90 ADORA1 (1.00) ADORA1MAPTMEN1KMT2ALMNA
Tinoridine SCHEMBL217049 0.89 ADORA1 (0.98) ADORA1MAPTMEN1KMT2ALMNA
SCHEMBL6990993 0.86 ADORA1 (0.75) ADORA1MAPTMEN1KMT2ALMNA
SCHEMBL6993930 0.82 MAPT (0.72) ADORA1MAPTMEN1KMT2ALMNA
SCHEMBL7000413 0.82 GAA (0.82) ADORA1MAPTMEN1KMT2ALMNA
SCHEMBL6993348 0.82 ADORA1 (0.71) ADORA1MAPTMEN1KMT2ALMNA
SCHEMBL14234268 0.81 ADORA1 (0.84) ADORA1MAPTMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0927184-B1 3-SUBSTITUTED PYRIDO 4',3':4,5]THIENO 2,3-D]PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE ABBOTT GMBH & CO KG (DE) 2003-10-22 EP disclosed
US-6387912-B1 STROKE THERAPY BASF AKTIENGESELLSCHAFT (DE) 2002-05-14 US disclosed
US-6222034-B1 AS SEROTININ RECEPTOR ANTAGONISTS; FOR THERAPY OF DEPRESSION, CENTRAL NERVOUS SYSTEM DISORDERS BASF AKTIENGESELLSCHAFT (DE) 2001-04-24 US disclosed